It's a common experience for those entering their 40s to notice a shift. Recovery from strenuous exercise isn't as swift as it once was. The afternoon energy slump that used to be occasional becomes a reliable 3 p.m. wall. You're doing everything roughly the same — sleep, diet, exercise — but the engine just doesn't feel like it's running at capacity.
There are a few things converging when this happens, but one of the least talked-about is also one of the most well-documented: the steady decline of a coenzyme called NAD+.
Your body doesn't send a notification about this. There's no calendar invite titled "NAD+ begins phased retirement — age 42" showing up in your inbox. You just notice the slump, the slower recovery, and the growing suspicion that whoever is running the energy department put in their two weeks without telling you.
Think of it this way: if your cells were a restaurant kitchen, ATP is the dish, NAD+ is the head chef, and the mitochondria are the stove. Fewer chefs at 50 than at 30 means slower service — the kitchen isn't shutting down, it's just running with a reduced crew. And researchers are actively studying how to staff it back up.
This isn't supplement marketing. It's basic cell biology, and the evidence over the last decade has made NAD+ one of the more interesting areas in healthy-aging science.
Here's how the mechanism works — and what the human research shows.
The Molecule Your Mitochondria Keep Asking For
NAD+ — nicotinamide adenine dinucleotide, if you want to lose a room quickly — is less interesting as a name than as a job description.
Your cells run on a molecule called ATP (adenosine triphosphate) — the fuel everything else in your body draws from. Mitochondria produce ATP by running electrons through a chain of molecular reactions. NAD+ is what keeps those electrons moving — it's the carrier molecule that makes the whole chain functional.
No NAD+, no electron transport. No electron transport, no ATP.
That's how foundational this molecule is. It's not a stimulant. It's not a shortcut. It's infrastructure. Human research has explored NAD+ in relation to cellular energy processes\* in the body.
The 40+ Decline: Why NAD+ Drops with Age
Here's the part that explains a lot.
Human research has documented that blood NAD+ levels tend to be lower in older adults, confirmed across multiple studies. (PMID: 32097708)
Two mechanisms have been studied in depth: enzymatic degradation of NAD+ by CD38 and consumption by DNA-repair enzymes including PARP-1 activated under cellular stress — both are documented in the research as contributors to declining NAD+ availability (PMID: 27304511; PMID: 29514063).
Together these mechanisms mean less NAD+ is available over time for the mitochondrial processes that generate ATP — a dynamic researchers continue to study in the context of healthy aging.
Why Researchers Study NMN Instead
Cells synthesize NAD+ internally from smaller precursor molecules rather than importing the full NAD+ molecule. This biology is why researchers have focused on NAD+ precursors — specifically NMN (nicotinamide mononucleotide), a smaller molecule that cells can transport via dedicated channels and convert to NAD+ through internal synthesis pathways. The clinical trials cited below all used NMN for exactly this reason.
What the Human Clinical Research Shows
The evidence base is stronger than most supplement discussions suggest. These are RCTs in human adults — not cell studies or animal models.
Yi et al. (2023) — An 80-person, double-blind, placebo-controlled study in middle-aged adults. The NMN group showed changes in blood NAD+ levels, physical performance measures, and self-reported vitality, with doses up to 900 mg/day well-tolerated. (PMID: 36482258)
Igarashi et al. (2022) — A 12-week RCT in older adults confirmed NMN elevated blood NAD+ and improved physical capacity metrics. (PMID: 35927255)
Liao et al. (2021) — A 6-week RCT in recreational runners found NMN combined with exercise improved aerobic capacity (VO₂max) compared to exercise training alone. (PMID: 34238308)
Song et al. (2023) — Systematic Review — Across human clinical trials, NMN showed a consistent safety profile. (PMID: 37619764)
The overall picture: multiple human trials in healthy adults with a favorable safety profile across the board.
FAQ
Q: Is NAD+ the same as NMN? A: No. NAD+ is the coenzyme your cells use directly for energy production. NMN is a precursor — a smaller molecule cells can import and convert to NAD+ internally. Supplementing with NMN is the approach backed by multiple human RCTs for this reason.
Q: When will I notice a difference? A: NMN isn't a stimulant — it's not going to feel like espresso. The trials that showed measurable outcomes ran over multiple weeks. Consult your healthcare professional about what makes sense for your situation.
Q: Is this only relevant for people who are already exhausted? A: Not at all. Declining NAD+ isn't a specific complaint — it's a gradual biological shift. Whether doing something about it makes sense for you is worth discussing with your healthcare professional.
The Bottom Line
NAD+ is central to how mitochondria generate energy, and research has documented its decline with age. NMN — a precursor with a growing human clinical trial record (PMID: 35499054) — shows a favorable safety profile across multiple RCTs.
Age Smarter. Live Stronger.
About the author — Roger Braun is the founder of Eternal Springs Bio, a NASM Certified Nutrition Coach, and a wellness entrepreneur with more than 14 years of experience in the dietary supplement industry. He earned his Bachelor's Degree in General Studies from Western Illinois University and has spent his career working with nutrition, supplement, and healthy-aging products.
Roger's writing focuses on the science of aging, metabolic health, gut health, immune support, and evidence-based nutrition strategies. He translates peer-reviewed research and supplement industry knowledge into clear, practical guidance for adults who want to better understand how nutrition, lifestyle, and targeted supplementation can support healthy aging in midlife and beyond.
Based on original ideas, research direction, and editorial review by the author, with AI-assisted drafting support.
This article is for informational purposes only — see the full disclosure below.
This article is for informational purposes only and is not medical advice. Do your own research and talk to your doctor before changing your diet, exercise routine, supplements, or health habits. The Food and Drug Administration has not evaluated these statements. If the above article mentions product(s), please know, These products are not intended to diagnose, treat, cure, or prevent any disease.